Research Article

Familial Hypercholesterolemia (FH) in Iran: Findings from the Four-Year FH Registry

Table 3

Baseline characteristics of subjects with familial hypercholesterolemia by cascade screening.

Possible ( (73.6%))Probable ( (12.4%))Definite ( (14.0%))Definite and probable ( (26.4%))Total ()

Demographics
 Sex (male)46 (48.4)8 (50.0)8 (44.4)16 (47.1)62 (48.1)
 Age (years)
Family history of premature CVDa39 (41.1)7 (43.8)3 (16.7)10 (29.4)49 (38.0)
Smoking status
 Never80 (84.2)13 (81.3)15 (83.3)28 (82.4)108 (83.7)
 Current9 (9.5)3 (18.8)2 (11.1)5 (14.7)14 (10.9)
 Previous6 (6.3)0 (0.0)1 (5.6)1 (2.9)7 (5.4)
Presence of Achille tendon0 (0)0 (0)4 (23.5)4 (12.1)4 (3.1)
Xanthomas0 (0)0 (0)8 (47.1)8 (24.2)8 (6.3)
Arcus cornealis0 (0)1 (6.3)2 (11.1)3 (8.8)3 (2.3)
Body mass index (kg/m2)
Comorbidities
 Hypertension24 (25.3)2 (12.5)1 (5.6)3 (8.8)27 (20.9)
 Diabetes mellitus13 (13.8)2 (12.5)5 (27.8)7 (20.6)20 (15.6)
 History of CVD31 (33.0)1 (6.3)5 (27.8)6 (17.6)37 (28.9)
Biochemical measures
 Total cholesterol (mg/dl)
 LDL-cholesterolb (mgr/dl)
 HDL-cholesterolc (mgr/dl)
 Non-HDL cholesterol (mg/dl)173.09-55.31
 Triglycerides (mgr/dl)
 FBSd
 HbA1ce
History of medication use
 Lipid-lowering drugs38 (40.0)9 (56.3)12 (66.7)21 (61.8)59 (45.7)
 Antihypertensive22 (23.2)3 (18.8)1 (5.6)4 (11.8)26 (20.2)
 Antidiabetics8 (8.4)1 (6.3)2 (11.1)3 (8.8)11 (8.5)
 Aspirin12 (12.6)2 (12.5)1 (5.6)3 (8.8)15 (11.6)

aCVD: cardiovascular disease. bLDL-cholesterol: low-density lipoprotein cholesterol. cHDL-cholesterol: high-density lipoprotein cholesterol. dFBS: fast blood sugar. eHbA1c: hemoglobin A1c.